T-cells are white blood cells that naturally combat disease as part of our immune system, but these artificially engineered versions would be targeted at specific forms of cancer, potentially giving our natural defences a boost in attacking the disease.
I have spent much of the last eight months touring neurological facilities across North America and meeting with a number of leading researchers and physicians. There are quite a few new treatments in the pipeline or in early stages of research that have the potential to revolutionize how we deal with Parkinson’s disease.
A malaria vaccine has been particularly elusive in the medical community because malaria originates from a parasite and not a virus. Therefore, a live but weakened form of the parasite that infects humans was used in the creation of this new investigational vaccine, Sanaria® PfSPZ. The weakened sporozoites parasite was developed by Sanaria Inc. through a clinical study conducted by researchers from the National Institute of Health’s (NIH)
A team of researchers from Sweden, France, Belgium and Switzerland has found a way to reverse resistance to an antibiotic drug used to treat tuberculosis. In their paper published in the journal Science, the team describes how they screened compounds that activated different pathways to activate ethionaide, a compound used to treat tuberculosis.
As far as cancers go, one of the worst is a type of brain cancer called glioma - the disease has a five-year survival rate of just 5 percent, and no reliable method for early detection.
A giant study that pooled genetic data from tens of thousands of people could change that, finding more than a dozen new mutations for physicians to hunt for in an effort to identify who is at risk of developing glioma.
Scientists at the Gladstone Institutes discovered a key mechanism that protects mice from developing a human disease of aging, and begins to explain the wide spectrum of disease severity often seen in humans. Both aspects center on the critical role of telomeres, protective caps on the ends of chromosomes that erode with age.
Researchers have developed a line immortal stem cells that allow them to generate an unlimited supply of artificial red blood cells on demand.
If these artificial blood cells pass clinical trials, they'll be far more efficient for medical use than current red blood cell products, which have to be generated from donor blood - and would be a huge deal for patients with rare blood types, who often struggle to find matching blood donors.
Don't Miss the Next Big Thing.
Stay Updated with Awesome Science Stuffs.